Market Cap 181.95B
Revenue (ttm) 29.44B
Net Income (ttm) 8.51B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 28.90%
Debt to Equity Ratio 2.23
Volume 5,259,100
Avg Vol 7,253,628
Day's Range N/A - N/A
Shares Out 1.24B
Stochastic %K 98%
Beta 0.32
Analysts Strong Sell
Price Target $158.34

Company Profile

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 650 574 3000
Fax: 650 522 5853
Address:
333 Lakeside Drive, Foster City, United States
focafoca99
focafoca99 Aug. 26 at 8:25 PM
$GILD speaks at three Q3 2026 investor conferences, starting with Wells Fargo on Sep 9. https://www.rapidticker.com/news/gild-gilead-sciences-to-present-at-b41243
0 · Reply
JFais
JFais Aug. 26 at 2:20 PM
$BHVN -interestingly, Vlad did not mention their oncology programs in the PR (perhaps the next to be licensed out for a high upfront payment?) Re recent comps, in April $GILD paid $3.15B upfront for Tubulis (NaPi2b in phase 1/2) $NVS $1.1B for Myricx Bio (B7-H3 & HER2) in July
1 · Reply
SniperAlphaCom
SniperAlphaCom Aug. 25 at 11:22 PM
$GILD broke out. Now the job changes. Position activated: **141.84** TS Update #1: **135.52** Once price confirms, I’m not trying to predict the next move. I’m managing risk and letting the trend do the work.
0 · Reply
opt_guru101
opt_guru101 Aug. 25 at 8:58 PM
$GILD new ATH coming
0 · Reply
destinyb5
destinyb5 Aug. 25 at 6:27 PM
0 · Reply
skcots_13
skcots_13 Aug. 25 at 4:55 PM
$GILD Been here for over 7 years. sometimes we like slow and steady is the case. GILD has several near-term catalysts, particularly regulatory decisions and pipeline updates, after a period of relatively steady performance. I realize these regulatory and commercial events are the primary potential catalysts that could move the stock after its multi-year relatively steady period. This stock should have been over $200 by now. Yet here I'm still here.
0 · Reply
destinyb5
destinyb5 Aug. 25 at 4:32 PM
$GILD this is gonna fly soon
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 25 at 1:30 PM
$CAPR don’t miss it $GILD $MRNA $MRK $LLY
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 25 at 11:34 AM
$MRNA and $GILD I told you to buy $CAPR didn’t I?
0 · Reply
TheStockTraderHub
TheStockTraderHub Aug. 25 at 3:45 AM
$GILD $145 PT HIT, stock is now flagging here on daily time frame with an inside bar close today. Looking for a retest on that all time highs trendline resistance once again to $150 area, a break & close over it opens room to $154/$157/$160+ in coming days. Support: $144/$142/$140
0 · Reply
Latest News on GILD
Gilead files automatic mixed securities shelf

2026-08-06T21:10:59.000Z - 20 days ago

Gilead files automatic mixed securities shelf


Gilead price target lowered to $150 from $156 at Truist

2026-08-05T14:08:38.000Z - 21 days ago

Gilead price target lowered to $150 from $156 at Truist


Gilead price target raised to $123 from $120 at RBC Capital

2026-08-05T11:46:58.000Z - 21 days ago

Gilead price target raised to $123 from $120 at RBC Capital


AHF Crowns Gilead Corporate Welfare King

Aug 4, 2026, 5:07 PM EDT - 22 days ago

AHF Crowns Gilead Corporate Welfare King


Gilead Sciences Earnings Call Transcript: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 22 days ago

Gilead Sciences Earnings Call Transcript: Q2 2026


Gilead Sciences Earnings release: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 22 days ago

Gilead Sciences Earnings release: Q2 2026


Gilead Sciences Slides: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 22 days ago

Gilead Sciences Slides: Q2 2026


Gilead Sciences Quarterly report: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 22 days ago

Gilead Sciences Quarterly report: Q2 2026


Gilead reports Q2 adjusted EPS ($6.75), consensus ($7.25)

2026-08-04T20:07:05.000Z - 22 days ago

Gilead reports Q2 adjusted EPS ($6.75), consensus ($7.25)


Gilead price target lowered to $145 from $155 at Barclays

2026-07-29T09:10:40.000Z - 4 weeks ago

Gilead price target lowered to $145 from $155 at Barclays


Gilead to present new HIV research at AIDS 2026

2026-07-21T14:10:37.000Z - 5 weeks ago

Gilead to present new HIV research at AIDS 2026


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


US FDA approves Gilead's drug for deadly liver infection

May 22, 2026, 2:06 PM EDT - 3 months ago

US FDA approves Gilead's drug for deadly liver infection


Gilead Prices $3 Billion of Senior Unsecured Notes

May 14, 2026, 9:21 PM EDT - 3 months ago

Gilead Prices $3 Billion of Senior Unsecured Notes


Gilead Sciences Expects Loss This Year on Acquired R&D Expenses

May 7, 2026, 4:39 PM EDT - 3 months ago

Gilead Sciences Expects Loss This Year on Acquired R&D Expenses


Gilead Sciences Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Gilead Sciences Earnings Call Transcript: Q1 2026


Gilead Sciences Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Gilead Sciences Slides: Q1 2026


Gilead Sciences Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Gilead Sciences Earnings release: Q1 2026


Gilead Sciences Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Gilead Sciences Quarterly report: Q1 2026


Gilead Sciences Announces First Quarter Financial Results

May 7, 2026, 4:01 PM EDT - 3 months ago

Gilead Sciences Announces First Quarter Financial Results


Gilead Sciences Slides: Investor presentation

May 7, 2026, 7:00 AM EDT - 3 months ago

Gilead Sciences Slides: Investor presentation


Can You Sue A Drug Company For Not Inventing Faster?

May 4, 2026, 5:15 AM EDT - 4 months ago

Can You Sue A Drug Company For Not Inventing Faster?


Gilead Sciences Transcript: AGM 2026

Apr 30, 2026, 1:00 PM EDT - 4 months ago

Gilead Sciences Transcript: AGM 2026


focafoca99
focafoca99 Aug. 26 at 8:25 PM
$GILD speaks at three Q3 2026 investor conferences, starting with Wells Fargo on Sep 9. https://www.rapidticker.com/news/gild-gilead-sciences-to-present-at-b41243
0 · Reply
JFais
JFais Aug. 26 at 2:20 PM
$BHVN -interestingly, Vlad did not mention their oncology programs in the PR (perhaps the next to be licensed out for a high upfront payment?) Re recent comps, in April $GILD paid $3.15B upfront for Tubulis (NaPi2b in phase 1/2) $NVS $1.1B for Myricx Bio (B7-H3 & HER2) in July
1 · Reply
SniperAlphaCom
SniperAlphaCom Aug. 25 at 11:22 PM
$GILD broke out. Now the job changes. Position activated: **141.84** TS Update #1: **135.52** Once price confirms, I’m not trying to predict the next move. I’m managing risk and letting the trend do the work.
0 · Reply
opt_guru101
opt_guru101 Aug. 25 at 8:58 PM
$GILD new ATH coming
0 · Reply
destinyb5
destinyb5 Aug. 25 at 6:27 PM
0 · Reply
skcots_13
skcots_13 Aug. 25 at 4:55 PM
$GILD Been here for over 7 years. sometimes we like slow and steady is the case. GILD has several near-term catalysts, particularly regulatory decisions and pipeline updates, after a period of relatively steady performance. I realize these regulatory and commercial events are the primary potential catalysts that could move the stock after its multi-year relatively steady period. This stock should have been over $200 by now. Yet here I'm still here.
0 · Reply
destinyb5
destinyb5 Aug. 25 at 4:32 PM
$GILD this is gonna fly soon
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 25 at 1:30 PM
$CAPR don’t miss it $GILD $MRNA $MRK $LLY
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 25 at 11:34 AM
$MRNA and $GILD I told you to buy $CAPR didn’t I?
0 · Reply
TheStockTraderHub
TheStockTraderHub Aug. 25 at 3:45 AM
$GILD $145 PT HIT, stock is now flagging here on daily time frame with an inside bar close today. Looking for a retest on that all time highs trendline resistance once again to $150 area, a break & close over it opens room to $154/$157/$160+ in coming days. Support: $144/$142/$140
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 24 at 8:14 PM
$CAPR just take note $GILD $MRNA
1 · Reply
StocktwitsNews
StocktwitsNews Aug. 24 at 8:04 PM
GILD Stock Garners Retail Attention On Trodelvy EU Approval Ahead Of August 27 HIV FDA Verdict $GILD $VTI $VOO https://stocktwits.com/news/equity/markets/gild-stock-garners-retail-attention-on-trodelvy-eu-approval-ahead-of-august-27-hiv-fda-verdict/cZYKrWjRJFm
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 24 at 6:53 PM
$GILD $MRNA don’t miss out on $CAPR 💰💰💰💰🚀🚀🚀🚀🚀🔥🔥🔥🔥🔥
2 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 24 at 6:47 PM
$CAPR the shorts should already know if I come knocking, you’re done ✅📈🔥💪🏻🥷🥂🚀 $GILD $MRNA
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 24 at 6:45 PM
$CAPR put your seatbelts on this last hour could get real crazy $GILD $MRNA the stock is legitimate. Look into it. Get in rocket
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 24 at 6:42 PM
Next wave 🌊 $MRNA $GILD LFG time to push $CAPR
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 24 at 6:36 PM
$CAPR send it $GILD $MRNA 💪🏻🔥🚀📈
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 24 at 6:34 PM
$CAPR congratulations, y’all. Keep pushing. almost there. $GILD $MRNA rocket now
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 24 at 6:29 PM
$MRNA and $GILD time to get in the $CAPR rocket 🚀
0 · Reply
Thinkingman91
Thinkingman91 Aug. 24 at 6:21 PM
0 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 24 at 6:16 PM
$CAPR the only thing keeping this down is the shorts, cause they already know they’re torched and fried. There’s no stopping this. I don’t care what anybody says by Friday this rocket’s to the moon $GILD $MRNA
2 · Reply
0pt1onsN1nja
0pt1onsN1nja Aug. 24 at 6:08 PM
$CAPR $1.30 under the high in pre market what does that tell you? $MRNA $GILD
1 · Reply